查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1460197

体外转录模板市场（疾病：癌症、传染病、生活方式疾病、遗传疾病等；以及治疗：疫苗和治疗）- 全球产业分析、规模、份额、成长、趋势和预测，2023-2031 年

In-vitro Transcription Templates Market (Disease: Cancer, Infectious Diseases, Lifestyle Diseases, Genetic Diseases, and Others; and Treatment: Vaccine and Therapeutic) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 233 Pages | 商品交期: 2-10个工作天内

价格

体外转录模板市场 - 报告范围

TMR 关于全球体外转录模板市场的报告研究了过去以及当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球体外转录模板市场的收入-2017- 2031年期间的体外转录模板市场，考虑2023年为基准年，2031年为预测年。报告中也提供了2023年至2031年全球体外转录模板市场的年复合成长率（CAGR %）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解体外转录模板市场。

市场概况
2022年市场价​​值 2.316 亿美元
2031 年市场价值 12亿美元
CAGR 20%

该报告深入研究了全球体外转录模板市场的竞争格局。全球体外转录模板市场的主要参与者已被确定，并且每一位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球体外转录范本市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2017-2031年全球市场分析与预测

第 5 章：关键见解

  • 管道分析
  • 主要产品/品牌分析
  • 主要併购
  • COVID-19 大流行对该行业的影响

第 6 章：全球市场分析与预测：依疾病分类

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依疾病分类，2017-2031
    • 癌症
      • 实体肿瘤
      • 大肠直肠癌
      • 非小细胞肺癌
      • 黑色素瘤
      • 白血病
      • 摄护腺癌
      • 其他的
    • 传染性疾病
      • 流感
      • 新冠肺炎
      • 爱滋病
      • 其他的
    • 生活方式疾病
    • 遗传疾病
    • 其他的
  • 市场吸引力：依疾病分类

第 7 章：全球市场分析与预测：按处理方式

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依处理方式，2017-2031
    • 疫苗
    • 治疗性
    • 7.4 市场吸引力：按待遇

第 8 章：全球市场分析与预测：依研究阶段划分

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依研究阶段，2017-2031
    • 探索性
    • 临床
  • 市场吸引力：依研究阶段划分

第 9 章：全球市场分析与预测：按最终用户

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2017-2031
    • 製药与生物技术公司
    • CRO 和 CMO
    • 学术与研究
    • 其他的
  • 市场吸引力：按最终用户划分

第 10 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2017-2031
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力：按地区

第 11 章：北美市场分析与预测

第 12 章：欧洲市场分析与预测

第 13 章：亚太市场分析与预测

第 14 章：拉丁美洲市场分析与预测

第 15 章：中东和非洲市场分析与预测

第16章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司划分（2022 年）
  • 公司简介
    • Thermo Fisher Scientific Inc.
    • Promega Corporation
    • Agilent Technologies, Inc.
    • New England Biolabs
    • Takara Bio Inc.
    • LGC Limited
    • Enzynomics Co. Ltd.
    • Enzo Life Sciences, Inc.
    • Danaher Corporation
Product Code: TMRGL43415

In-vitro Transcription Templates Market - Scope of Report

TMR's report on the global in-vitro transcription templates market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global in-vitro transcription templates market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global in-vitro transcription templates market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the in-vitro transcription templates market.

Market Snapshot
Market Value in 2022US$ 231.6 Mn
Market Value in 2031US$ 1.2 Bn
CAGR20%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global in-vitro transcription templates market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global in-vitro transcription templates market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global in-vitro transcription templates market.

The report delves into the competitive landscape of the global in-vitro transcription templates market. Key players operating in the global in-vitro transcription templates market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global in-vitro transcription templates market profiled in this report.

Key Questions Answered in Global in-vitro transcription templates Market Report:

  • What is the sales/revenue generated by in-vitro transcription templates across all regions during the forecast period?
  • What are the opportunities in the global in-vitro transcription templates market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

In-vitro Transcription Templates Market - Research Objectives and Research Approach

The comprehensive report on the global in-vitro transcription templates market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global in-vitro transcription templates market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global in-vitro transcription templates market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global In-vitro Transcription Templates Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global In-vitro Transcription Templates Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global In-vitro Transcription Templates Market Analysis and Forecast, by Disease

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Disease, 2017-2031
    • 6.3.1. Cancer
      • 6.3.1.1. Solid Tumors
      • 6.3.1.2. Colorectal Cancer
      • 6.3.1.3. NSCLC
      • 6.3.1.4. Melanoma
      • 6.3.1.5. Leukemia
      • 6.3.1.6. Prostate Cancer
      • 6.3.1.7. Others
    • 6.3.2. Infectious Diseases
      • 6.3.2.1. Influenza
      • 6.3.2.2. COVID-19
      • 6.3.2.3. AIDS
      • 6.3.2.4. Others
    • 6.3.3. Lifestyle Diseases
    • 6.3.4. Genetic Diseases
    • 6.3.5. Others
  • 6.4. Market Attractiveness, by Disease

7. Global In-vitro Transcription Templates Market Analysis and Forecast, by Treatment

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Treatment, 2017-2031
    • 7.3.1. Vaccine
    • 7.3.2. Therapeutic
    • 7.3.3. 7.4 Market Attractiveness, by Treatment

8. Global In-vitro Transcription Templates Market Analysis and Forecast, by Research Stage

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Research Stage, 2017-2031
    • 8.3.1. Exploratory
    • 8.3.2. Clinical
  • 8.4. Market Attractiveness, by Research Stage

9. Global In-vitro Transcription Templates Market Analysis and Forecast, by End-user

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Pharmaceutical & Biotechnology Companies
    • 9.3.2. CROs & CMOs
    • 9.3.3. Academics & Research
    • 9.3.4. Others
  • 9.4. Market Attractiveness, by End-user

10. Global In-vitro Transcription Templates Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2017-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness, by Region

11. North America In-vitro Transcription Templates Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Disease, 2017-2031
    • 11.2.1. Cancer
      • 11.2.1.1. Solid Tumors
      • 11.2.1.2. Colorectal Cancer
      • 11.2.1.3. NSCLC
      • 11.2.1.4. Melanoma
      • 11.2.1.5. Leukemia
      • 11.2.1.6. Prostate Cancer
      • 11.2.1.7. Others
    • 11.2.2. Infectious Diseases
      • 11.2.2.1. Influenza
      • 11.2.2.2. COVID-19
      • 11.2.2.3. AIDS
      • 11.2.2.4. Others
    • 11.2.3. Lifestyle Diseases
    • 11.2.4. Genetic Diseases
    • 11.2.5. Others
  • 11.3. Market Attractiveness, by Disease
  • 11.4. Market Value Forecast, by Treatment, 2017-2031
    • 11.4.1. Vaccine
    • 11.4.2. Therapeutic
  • 11.5. Market Attractiveness, by Treatment
  • 11.6. Market Value Forecast, by Research Stage, 2017-2031
    • 11.6.1. Exploratory
    • 11.6.2. Clinical
  • 11.7. Market Attractiveness, by Research Stage
  • 11.8. Market Value Forecast, by End-user, 2017-2031
    • 11.8.1. Pharmaceutical & Biotechnology Companies
    • 11.8.2. CROs & CMOs
    • 11.8.3. Academics & Research
    • 11.8.4. Others
  • 11.9. Market Attractiveness, by End-user
  • 11.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.10.1. U.S.
    • 11.10.2. Canada
  • 11.11. Market Attractiveness Analysis
    • 11.11.1. By Disease
    • 11.11.2. By Treatment
    • 11.11.3. By Research Stage
    • 11.11.4. By End-user
    • 11.11.5. By Country

12. Europe In-vitro Transcription Templates Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Disease, 2017-2031
    • 12.2.1. Cancer
      • 12.2.1.1. Solid Tumors
      • 12.2.1.2. Colorectal Cancer
      • 12.2.1.3. NSCLC
      • 12.2.1.4. Melanoma
      • 12.2.1.5. Leukemia
      • 12.2.1.6. Prostate Cancer
      • 12.2.1.7. Others
    • 12.2.2. Infectious Diseases
      • 12.2.2.1. Influenza
      • 12.2.2.2. COVID-19
      • 12.2.2.3. AIDS
      • 12.2.2.4. Others
    • 12.2.3. Lifestyle Diseases
    • 12.2.4. Genetic Diseases
    • 12.2.5. Others
  • 12.3. Market Attractiveness, by Disease
  • 12.4. Market Value Forecast, by Treatment, 2017-2031
    • 12.4.1. Vaccine
    • 12.4.2. Therapeutic
  • 12.5. Market Attractiveness, by Treatment
  • 12.6. Market Value Forecast, by Research Stage, 2017-2031
    • 12.6.1. Exploratory
    • 12.6.2. Clinical
  • 12.7. Market Attractiveness, by Research Stage
  • 12.8. Market Value Forecast, by End-user, 2017-2031
    • 12.8.1. Pharmaceutical & Biotechnology Companies
    • 12.8.2. CROs & CMOs
    • 12.8.3. Academics & Research
    • 12.8.4. Others
  • 12.9. Market Attractiveness, by End-user
  • 12.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.10.1. Germany
    • 12.10.2. U.K.
    • 12.10.3. France
    • 12.10.4. Italy
    • 12.10.5. Spain
    • 12.10.6. Rest of Europe
  • 12.11. Market Attractiveness Analysis
    • 12.11.1. By Disease
    • 12.11.2. By Treatment
    • 12.11.3. By Research Stage
    • 12.11.4. By End-user
    • 12.11.5. By Country/Sub-region

13. Asia Pacific In-vitro Transcription Templates Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Disease, 2017-2031
    • 13.2.1. Cancer
      • 13.2.1.1. Solid Tumors
      • 13.2.1.2. Colorectal Cancer
      • 13.2.1.3. NSCLC
      • 13.2.1.4. Melanoma
      • 13.2.1.5. Leukemia
      • 13.2.1.6. Prostate Cancer
      • 13.2.1.7. Others
    • 13.2.2. Infectious Diseases
      • 13.2.2.1. Influenza
      • 13.2.2.2. COVID-19
      • 13.2.2.3. AIDS
      • 13.2.2.4. Others
    • 13.2.3. Lifestyle Diseases
    • 13.2.4. Genetic Diseases
    • 13.2.5. Others
  • 13.3. Market Attractiveness, by Disease
  • 13.4. Market Value Forecast, by Treatment, 2017-2031
    • 13.4.1. Vaccine
    • 13.4.2. Therapeutic
  • 13.5. Market Attractiveness, by Treatment
  • 13.6. Market Value Forecast, by Research Stage, 2017-2031
    • 13.6.1. Exploratory
    • 13.6.2. Clinical
  • 13.7. Market Attractiveness, by Research Stage
  • 13.8. Market Value Forecast, by End-user, 2017-2031
    • 13.8.1. Pharmaceutical & Biotechnology Companies
    • 13.8.2. CROs & CMOs
    • 13.8.3. Academics & Research
    • 13.8.4. Others
  • 13.9. Market Attractiveness, by End-user
  • 13.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.10.1. China
    • 13.10.2. Japan
    • 13.10.3. India
    • 13.10.4. Australia & New Zealand
    • 13.10.5. Rest of Asia Pacific
  • 13.11. Market Attractiveness Analysis
    • 13.11.1. By Disease
    • 13.11.2. By Treatment
    • 13.11.3. By Research Stage
    • 13.11.4. By End-user
    • 13.11.5. By Country/Sub-region

14. Latin America In-vitro Transcription Templates Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Disease, 2017-2031
    • 14.2.1. Cancer
      • 14.2.1.1. Solid Tumors
      • 14.2.1.2. Colorectal Cancer
      • 14.2.1.3. NSCLC
      • 14.2.1.4. Melanoma
      • 14.2.1.5. Leukemia
      • 14.2.1.6. Prostate Cancer
      • 14.2.1.7. Others
    • 14.2.2. Infectious Diseases
      • 14.2.2.1. Influenza
      • 14.2.2.2. COVID-19
      • 14.2.2.3. AIDS
      • 14.2.2.4. Others
    • 14.2.3. Lifestyle Diseases
    • 14.2.4. Genetic Diseases
    • 14.2.5. Others
  • 14.3. Market Attractiveness, by Disease
  • 14.4. Market Value Forecast, by Treatment, 2017-2031
    • 14.4.1. Vaccine
    • 14.4.2. Therapeutic
  • 14.5. Market Attractiveness, by Treatment
  • 14.6. Market Value Forecast, by Research Stage, 2017-2031
    • 14.6.1. Exploratory
    • 14.6.2. Clinical
  • 14.7. Market Attractiveness, by Research Stage
  • 14.8. Market Value Forecast, by End-user, 2017-2031
    • 14.8.1. Pharmaceutical & Biotechnology Companies
    • 14.8.2. CROs & CMOs
    • 14.8.3. Academics & Research
    • 14.8.4. Others
  • 14.9. Market Attractiveness, by End-user
  • 14.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.10.1. Brazil
    • 14.10.2. Mexico
    • 14.10.3. Rest of Latin America
  • 14.11. Market Attractiveness Analysis
    • 14.11.1. By Disease
    • 14.11.2. By Treatment
    • 14.11.3. By Research Stage
    • 14.11.4. By End-user
    • 14.11.5. By Country/Sub-region

15. Middle East & Africa In-vitro Transcription Templates Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Disease, 2017-2031
    • 15.2.1. Cancer
      • 15.2.1.1. Solid Tumors
      • 15.2.1.2. Colorectal Cancer
      • 15.2.1.3. NSCLC
      • 15.2.1.4. Melanoma
      • 15.2.1.5. Leukemia
      • 15.2.1.6. Prostate Cancer
      • 15.2.1.7. Others
    • 15.2.2. Infectious Diseases
      • 15.2.2.1. Influenza
      • 15.2.2.2. COVID-19
      • 15.2.2.3. AIDS
      • 15.2.2.4. Others
    • 15.2.3. Lifestyle Diseases
    • 15.2.4. Genetic Diseases
    • 15.2.5. Others
  • 15.3. Market Attractiveness, by Disease
  • 15.4. Market Value Forecast, by Treatment, 2017-2031
    • 15.4.1. Vaccine
    • 15.4.2. Therapeutic
  • 15.5. Market Attractiveness, by Treatment
  • 15.6. Market Value Forecast, by Research Stage, 2017-2031
    • 15.6.1. Exploratory
    • 15.6.2. Clinical
  • 15.7. Market Attractiveness, by Research Stage
  • 15.8. Market Value Forecast, by End-user, 2017-2031
    • 15.8.1. Pharmaceutical & Biotechnology Companies
    • 15.8.2. CROs & CMOs
    • 15.8.3. Academics & Research
    • 15.8.4. Others
  • 15.9. Market Attractiveness, by End-user
  • 15.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.10.1. GCC Countries
    • 15.10.2. South Africa
    • 15.10.3. Rest of Middle East & Africa
  • 15.11. Market Attractiveness Analysis
    • 15.11.1. By Disease
    • 15.11.2. By Treatment
    • 15.11.3. By Research Stage
    • 15.11.4. By End-user
    • 15.11.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. Thermo Fisher Scientific Inc.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Promega Corporation
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Agilent Technologies, Inc.
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. New England Biolabs
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Takara Bio Inc.
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. LGC Limited
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Enzynomics Co. Ltd.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Enzo Life Sciences, Inc.
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Danaher Corporation
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview

List of Tables

  • Table 01: Global In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Disease, 2017-2031
  • Table 02: Global In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 03: Global In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Research Stage, 2017-2031
  • Table 05: Global In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Disease, 2017-2031
  • Table 08: North America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 9: North America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Research Stage, 2017-2031
  • Table 10: North America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 11: Europe In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Disease, 2017-2031
  • Table 13: Europe In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 14: Europe In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Research Stage, 2017-2031
  • Table 15: Europe In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Asia Pacific In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Disease, 2017-2031
  • Table 18: Asia Pacific In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 19: Asia Pacific In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Research Stage, 2017-2031
  • Table 20: Asia Pacific In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Latin America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Disease, 2017-2031
  • Table 23: Latin America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 24: Latin America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Research Stage, 2017-2031
  • Table 25: Latin America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 26: Middle East & Africa In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Disease, 2017-2031
  • Table 28: Middle East & Africa In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 29: Middle East & Africa In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Research Stage, 2017-2031
  • Table 30: Middle East & Africa In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global In-vitro Transcription Templates Market Size (US$ Mn), by Region, 2022-2031
  • Figure 02: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Disease, 2022
  • Figure 03: Global In-vitro Transcription Templates Market Value Share, by Disease, 2022
  • Figure 04: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Treatment, 2022
  • Figure 05: Global In-vitro Transcription Templates Market Value Share, by Treatment, 2022
  • Figure 06: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Research Stage, 2022
  • Figure 07: Global In-vitro Transcription Templates Market Value Share, by Research Stage, 2022
  • Figure 08: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by End-user, 2022
  • Figure 09: Global In-vitro Transcription Templates Market Value Share, by End-user, 2022
  • Figure 10: Global In-vitro Transcription Templates Market Value Share, by Region, 2022
  • Figure 11: Global In-vitro Transcription Templates Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 12: Global In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2022-2031
  • Figure 13: Global In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2023-2031
  • Figure 14: Global In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2022-2031
  • Figure 15: Global In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 16: Global In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2022-2031
  • Figure 17: Global In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2023-2031
  • Figure 18: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by End-user, 2022
  • Figure 19: Global In-vitro Transcription Templates Market Value Share, by End-user, 2022
  • Figure 20: Global In-vitro Transcription Templates Market Value Share Analysis, by Region, 2022-2031
  • Figure 21: Global In-vitro Transcription Templates Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 22: North America In-vitro Transcription Templates Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 23: North America In-vitro Transcription Templates Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 24: North America In-vitro Transcription Templates Market Value Share Analysis, by Country, 2022-2031
  • Figure 25: North America In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2022-2031
  • Figure 26: North America In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2022-2031
  • Figure 27: North America In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2022-2031
  • Figure 28: North America In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2022-2031
  • Figure 29: North America In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2023-2031
  • Figure 30: North America In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 31: North America In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2023-2031
  • Figure 32: North America In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 33: Europe In-vitro Transcription Templates Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 34: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 35: Europe In-vitro Transcription Templates Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 36: Europe In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2022-2031
  • Figure 37: Europe In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2022-2031
  • Figure 38: Europe In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2022-2031
  • Figure 39: Europe In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2022-2031
  • Figure 40: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2023-2031
  • Figure 41: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 42: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2023-2031
  • Figure 43: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 44: Asia Pacific In-vitro Transcription Templates Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 45: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 46: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 47: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2022-2031
  • Figure 48: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2022-2031
  • Figure 49: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2022-2031
  • Figure 50: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2022-2031
  • Figure 51: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2023-2031
  • Figure 52: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 53: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2023-2031
  • Figure 54: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 55: Latin America In-vitro Transcription Templates Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 56: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 57: Latin America In-vitro Transcription Templates Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 58: Latin America In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2022-2031
  • Figure 59: Latin America In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2022-2031
  • Figure 60: Latin America In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2022-2031
  • Figure 61: Latin America In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2022-2031
  • Figure 62: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2023-2031
  • Figure 63: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 64: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2023-2031
  • Figure 65: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 66: Middle East & Africa In-vitro Transcription Templates Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 67: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 68: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 69: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2022-2031
  • Figure 70: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2022-2031
  • Figure 71: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2022-2031
  • Figure 72: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2022-2031
  • Figure 73: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2023-2031
  • Figure 74: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 75: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2023-2031
  • Figure 76: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2023-2031